Step aside, semaglutide—retatrutide is showing the most impressive weight loss results of any obesity drug to date.

Every January, many people decide they want to improve their health and bring their weight to a safer range. Most resolutions ...

At the end of the day, GLP-1s can be a powerful tool for achieving your weight loss goals, but only if they're safe and ...

Grade 2 fatty liver, specifically, indicates a moderate level of fat within the liver, often requiring attention to prevent ...

PCOS (Polycystic Ovary Syndrome) is one of the common hormonal disorders that is interconnected to weight changes in women.

Eli Lilly is putting the "obesity field on notice again," an analyst said Thursday after its next-gen delivered 28.7% weight ...

Novo Nordisk said a weight-loss drug candidate helped patients lose weight and reduce blood-sugar levels in pill and injection forms during a mid-stage trial, lifting shares in the company. The Danish ...

Mississippi is bracing for a surge in obesity rates — and launching new programs, policies and school initiatives to fight ...

Novo Nordisk said a new weight-loss drug candidate led to weight loss and diabetes reductions in both injection and pill versions during a mid-stage trial. The Danish pharmaceutical company said ...

Globally, more than 1 billion people currently live with obesity. The World Health Organization on Monday released new guidance on GLP-1 medications for adults with obesity, recommending their ...

Lilly’s closely watched retatrutide spurred as much as 29% weight loss in a Phase 3 study, a finding that is “raising the bar ...

A new weight loss pill has shown promise as a more convenient medication for adults with obesity and type 2 diabetes. The once-daily pill appears to be effective and safe for these patients, according ...